BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

702 related articles for article (PubMed ID: 23810175)

  • 41. Comparison of survival and recurrence pattern between two-field and three-field lymph node dissections for upper thoracic esophageal squamous cell carcinoma.
    Shim YM; Kim HK; Kim K
    J Thorac Oncol; 2010 May; 5(5):707-12. PubMed ID: 20421764
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Feasibility and safety of radical mediastinal lymphadenectomy in thoracoscopic esophagectomy for esophageal cancer].
    Zhang Y; Tan LJ; Feng MX; Wang H; Wang Q
    Zhonghua Zhong Liu Za Zhi; 2012 Nov; 34(11):855-9. PubMed ID: 23291137
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Node status in transmural esophageal adenocarcinoma and outcome after en bloc esophagectomy.
    Nigro JJ; DeMeester SR; Hagen JA; DeMeester TR; Peters JH; Kiyabu M; Campos GM; Oberg S; Gastal O; Crookes PF; Bremner CG
    J Thorac Cardiovasc Surg; 1999 May; 117(5):960-8. PubMed ID: 10220691
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reflections on three field lymphadenectomy in carcinoma of the esophagus and gastroesophageal junction.
    Lerut T; Coosemans W; De Leyn P; Deneffe G; Topal B; Van de Ven C; Van Raemdonck D
    Hepatogastroenterology; 1999; 46(26):717-25. PubMed ID: 10370600
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Three-field lymphadenectomy for carcinoma of the esophagus and gastroesophageal junction in 174 R0 resections: impact on staging, disease-free survival, and outcome: a plea for adaptation of TNM classification in upper-half esophageal carcinoma.
    Lerut T; Nafteux P; Moons J; Coosemans W; Decker G; De Leyn P; Van Raemdonck D; Ectors N
    Ann Surg; 2004 Dec; 240(6):962-72; discussion 972-4. PubMed ID: 15570202
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Causes of death and pattern of recurrence after esophagectomy and extended lymphadenectomy for squamous cell carcinoma of the thoracic esophagus.
    Osugi H; Takemura M; Higashino M; Takada N; Lee S; Ueno M; Tanaka Y; Fukuhara K; Hashimoto Y; Fujiwara Y; Kinoshita H
    Oncol Rep; 2003; 10(1):81-7. PubMed ID: 12469149
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of number and site of lymph node invasion on survival of adenocarcinoma of esophagogastric junction.
    Ielpo B; Pernaute AS; Elia S; Buonomo OC; Valladares LD; Aguirre EP; Petrella G; Garcia AT
    Interact Cardiovasc Thorac Surg; 2010 May; 10(5):704-8. PubMed ID: 20154347
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characteristics and clinical significance of lymph node metastases near the recurrent laryngeal nerve from thoracic esophageal carcinoma.
    Ye K; Xu JH; Sun YF; Lin JA; Zheng ZG
    Genet Mol Res; 2014 Aug; 13(3):6411-9. PubMed ID: 25158259
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Clinical outcomes and selection conditions of three-field lymph node dissection for thoracic esophageal squamous cell carcinoma].
    Fang Q; Han YT; Wang SX; Ren GG; Peng L; Xiao WG; Chen LH
    Zhonghua Zhong Liu Za Zhi; 2012 Mar; 34(3):212-5. PubMed ID: 22780977
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical study of modified Ivor-Lewis esophagectomy plus adjuvant radiotherapy for local control of stage IIA squamous cell carcinoma in the mid-thoracic esophagus.
    Chen G; Wang Z; Liu XY; Zhang MY; Liu FY
    Eur J Cardiothorac Surg; 2009 Jan; 35(1):1-7. PubMed ID: 18926712
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Predictive value of log odds of positive lymph nodes for the prognosis of patients with node-negative squamous cell carcinoma of the thoracic esophagus after radical esophagectomy].
    Yang M; Zhang H; Huo X; Chen C; Yu Z
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 May; 19(5):535-9. PubMed ID: 27215521
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison between radical esophagectomy and definitive chemoradiotherapy in patients with clinical T1bN0M0 esophageal cancer.
    Motoori M; Yano M; Ishihara R; Yamamoto S; Kawaguchi Y; Tanaka K; Kishi K; Miyashiro I; Fujiwara Y; Shingai T; Noura S; Ohue M; Ohigashi H; Nakamura S; Ishikawa O
    Ann Surg Oncol; 2012 Jul; 19(7):2135-41. PubMed ID: 22302264
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Lymphatic metastasis intensity of and lymphadenectomy for thoracic esophageal squamous cell carcinoma].
    Lu ZM; Zhang H; Wang MH; Cui DH; Yang YQ; Huang HZ
    Ai Zheng; 2006 May; 25(5):604-8. PubMed ID: 16687083
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pathologic lymph node staging practice and stage-predicted survival after resection of lung cancer.
    Osarogiagbon RU; Allen JW; Farooq A; Berry A; O'Brien T
    Ann Thorac Surg; 2011 May; 91(5):1486-92. PubMed ID: 21524460
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The significance of abdominal para-aortic lymph node metastasis in patients with lower thoracic esophageal cancer.
    Tanaka K; Yano M; Motoori M; Doki Y; Kishi K; Miyashiro I; Shingai T; Gotoh K; Noura S; Takahashi H; Ohue M; Yamada T; Ohigashi H; Ishikawa O
    Dis Esophagus; 2012 Feb; 25(2):146-52. PubMed ID: 21762280
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Cutaneous malignant melanoma of the head and neck with intermediate tumor thickness: the role of elective lymph node dissection for clinical stage I].
    Wenzel S; Sagowski C; Neuber K; Kehrl W; Metternich FU
    Laryngorhinootologie; 2003 Jan; 82(1):19-24. PubMed ID: 12548460
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Outcomes of cervical lymph node recurrence in patients with esophageal squamous cell carcinoma after esophagectomy with 2-field lymph node dissection.
    Lee DH; Kim HR; Kim DK; Park SI; Kim YH
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):365-71. PubMed ID: 23422046
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment outcome and prognosis of patients with lymph node recurrence of thoracic esophageal squamous cell carcinoma after curative resection.
    Kosuga T; Shiozaki A; Fujiwara H; Ichikawa D; Okamoto K; Komatsu S; Otsuji E
    World J Surg; 2011 Apr; 35(4):798-804. PubMed ID: 21312037
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nodal skip metastasis is not a predictor of survival in thoracic esophageal squamous cell carcinoma.
    Zhu Z; Yu W; Li H; Zhao K; Zhao W; Zhang Y; Sun M; Wei Q; Chen H; Xiang J; Fu X
    Ann Surg Oncol; 2013 Sep; 20(9):3052-8. PubMed ID: 23686016
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Early-stage adenocarcinoma of the esophagus with mid to deep submucosal invasion (pT1b sm2-3): the frequency of lymph-node metastasis depends on macroscopic and histological risk patterns.
    Manner H; Wetzka J; May A; Pauthner M; Pech O; Fisseler-Eckhoff A; Stolte M; Vieth M; Lorenz D; Ell C
    Dis Esophagus; 2017 Feb; 30(3):1-11. PubMed ID: 26952572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.